Assignee
TRANSCEND THERAPEUTICS INC
US·9 granted patents·7 pending applications·45 citations·filing 1995–2025
Top patents by PatentIndex Score
16 records- 0192US11707446B2Psychoactive medicines and their use for treating psychiatric and neurological conditions and disordersTRANSCEND THERAPEUTICS INC·Filed 2022·Granted Jul 25, 2023·4 cites·28 claims
- 0288US2026083699A1Psychoactive medicines and their use for treating psychiatric and neurological conditions and disordersTRANSCEND THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0387US12233046B2Psychoactive medicines and their use for treating psychiatric and neurological conditions and disordersTRANSCEND THERAPEUTICS INC·Filed 2024·Granted Feb 25, 2025·0 cites·29 claims
- 0484US11969407B2Psychoactive medicines and their use for treating psychiatric and neurological conditions and disordersTRANSCEND THERAPEUTICS INC·Filed 2023·Granted Apr 30, 2024·0 cites·30 claims
- 0583US12059402B2Psychoactive medicines and their use for treating psychiatric and neurological conditions and disordersTRANSCEND THERAPEUTICS INC·Filed 2023·Granted Aug 13, 2024·0 cites·13 claims
- 0677US12297220B2Phenethylamines and cathinones precursorsTRANSCEND THERAPEUTICS INC·Filed 2024·Granted May 13, 2025·0 cites·8 claims
- 0774US5824693AMethod for treatment for pulmonary diseaseTRANSCEND THERAPEUTICS INC·Filed 1995·Granted Oct 20, 1998·36 cites·17 claims
- 0874US2024327372A1Preparation of phenethylamines and cathinones and stereoisomers thereof and precursors thereofTRANSCEND THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0974US2024374558A1Preparation of phenethylamines and cathinones and stereoisomers thereof and precursors thereofTRANSCEND THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1073US12343326B2Psychoactive medicines and their use for treating psychiatric and neurological conditions and disordersTRANSCEND THERAPEUTICS INC·Filed 2024·Granted Jul 1, 2025·0 cites·5 claims
- 1171US2025255846A1Psychoactive medicines and their use for treating psychiatric and neurological conditions and disordersTRANSCEND THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1266US12295937B2Psychoactive medicines and their use for treating psychiatric and neurological conditions and disordersTRANSCEND THERAPEUTICS INC·Filed 2024·Granted May 13, 2025·0 cites·30 claims
- 1361US2025270242A1Phenethylamines and cathinones precursorsTRANSCEND THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1459US2025221957A1Psychoactive medicines and their use for treating psychiatric and neurological conditions and disordersTRANSCEND THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1551US2025332139A1Psychoactive medicines and their use for treating psychiatric and neurological conditions and disordersTRANSCEND THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1648US5869679AMethods for preparing l-2-oxothiazolidine-4-carboxylate and its carboxylic acidTRANSCEND THERAPEUTICS INC·Filed 1997·Granted Feb 9, 1999·5 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when TRANSCEND THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →